Invesco Ltd. Acquires 1,724 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Invesco Ltd. raised its holdings in Aspen Aerogels, Inc. (NYSE:ASPN) by 3.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 50,871 shares of the construction company’s stock after buying an additional 1,724 shares during the quarter. Invesco Ltd. owned 0.06% of Aspen Aerogels worth $604,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Barclays PLC lifted its position in shares of Aspen Aerogels by 333.8% during the 3rd quarter. Barclays PLC now owns 92,302 shares of the construction company’s stock valued at $2,557,000 after acquiring an additional 71,024 shares during the period. Wilmington Savings Fund Society FSB bought a new position in shares of Aspen Aerogels during the 3rd quarter worth about $498,000. Franklin Resources Inc. grew its stake in shares of Aspen Aerogels by 5.3% in the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after buying an additional 1,483 shares during the period. Lord Abbett & CO. LLC acquired a new stake in shares of Aspen Aerogels in the 3rd quarter valued at about $10,126,000. Finally, Talbot Financial LLC bought a new stake in Aspen Aerogels in the 4th quarter valued at about $251,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ASPN has been the subject of a number of research reports. B. Riley reduced their price objective on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research note on Wednesday, February 19th. Barclays reduced their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research report on Wednesday, February 19th. Roth Mkm lowered their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Friday, February 14th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, February 19th. Finally, Canaccord Genuity Group lowered their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average price target of $19.11.

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $5.82 on Friday. The company has a market capitalization of $477.85 million, a PE ratio of 36.38 and a beta of 2.72. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The stock’s 50 day moving average price is $6.30 and its 200-day moving average price is $11.18. Aspen Aerogels, Inc. has a twelve month low of $4.80 and a twelve month high of $33.15.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.